BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Allergy to pollen
,
Lung
,
Autoimmunity
,
Valproic acid
,
rs2476601
,
SNCA
,
Angiogenesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
poorly differentiated adenocarcinoma
Summary
General Info
Curated Studies
Most Correlated Studies
expO project: Colorectal Cancer Subset
expO project: Endometrial cancer subset
Esophageal adenocarcinoma and Barrett's esophagus global gene expression signatures
Uterine serouscarcinoma gene expression compared to endometrioid adenocarcinomas
Renal cell carcinomas with different pathologic parameters and metastases
Explore Curated Studies Results
Literature
Most Relevant Literature
SMARCA4-Deficient Poorly Differentiated Adenocarcinoma of the Gallbladder.
Magnifying endoscopic findings of early-stage poorly differentiated colorectal adenocarcinoma: a cas…
68 Ga-FAPI PET/CT Detection of Non-FDG-Avid Poorly Differentiated Adenocarcinoma of the Trachea.
FDG PET/CT in a Case With Primary Poorly Differentiated Urothelial-Type Adenocarcinoma of the Prosta…
18F-FDG and 18F-Fluciclovine Uptake in Poorly Differentiated Lung Adenocarcinoma in the Setting of B…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Poorly Differentiated Adenocarcinoma With Signet Ring Cells of the Gallbladder Producing a High Leve…
Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endoc…
Chemotherapy For Metastatic Grade 3 Poorly Differentiated NEuroendocrine Carcinoma Of GastroEnteroPa…
Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocri…
Nivolumab +/- Ipilimumab in Patients With Advanced, Refractory Pulmonary or Gastroenteropancreatic P…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ